Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1993-12-15
1998-02-24
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514573, 514913, A61K 31215, A61K 3119
Patent
active
057212732
ABSTRACT:
9-Halo-13,14-dihydroprostaglandins are useful in the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic, pharmaceutical compositions comprising such prostaglandins.
REFERENCES:
patent: 4444788 (1984-04-01), Skuballa et al.
patent: 4454339 (1984-06-01), Skuballa et al.
patent: 4789685 (1988-12-01), Skuballa et al.
patent: 5004752 (1991-04-01), Raduechel et al.
patent: 5079259 (1992-01-01), Skuballa et al.
patent: 5093329 (1992-03-01), Woodward
patent: 5204371 (1993-04-01), Skuballa et al.
Braun, et al., "Effect of ZK 110.841 on Cerebral Vascular Contraction and TXA.sub.2 -Release Caused by Thrombin-Stimulated Platets," Archives of Pharmacology, 339 Suppl:R37(148) (1989).
Ney, "Potent Inhibition of FMLP-Induced Neutrophil Activation by the PGD.sub.2 Analogue ZK 110.841," Archives of Pharmacology, 339 Suppl:R38 (150) (1989).
"New Research Drug DLO/8149" Drug License Opportunities (IMSWORLD Publications) (Jun. 25, 1990).
Buchmann et al., "Synthesis of a Chemical and Metabolically Stable and Biologically Potent PGD.sub.2 -Analogue," Tetrahedron Letters, 31(24):3425-3428 (1990).
Nakajima et al., Graefe's Arch. Clin. Exp. Ophthalmol., 229:411-413 (1991).
Woodward et al., Invest. Ophthalmol. Vis. Sci., 31:138-146 (1990).
Thierauch et al., Prostaglandins, 35:6:855-868 (1988).
Goh et al., Graefe's Arch. Clin. Exp. Ophthalmol., 227:476-481 (1989).
Thierauch, et al., Advances in Prostaglandin, Thromboxane and Leukotriene Research, 19:655-658 (1989).
Woodward et al., Invest. Ophthal. & Vis. Sci., 31:1:138-146 (1990).
Chemical Abstracts 113:211633, 1990. Buchmann et al.
Bishop John E.
DeSantis, Jr. Louis
Sallee Verney L.
Zinke Paul W.
Alcon Laboratories Inc.
Copeland Barry L.
Fay Zohreh
LandOfFree
Use of certain 9-halo-13,14-dihydroprostaglandins to treat glauc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of certain 9-halo-13,14-dihydroprostaglandins to treat glauc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of certain 9-halo-13,14-dihydroprostaglandins to treat glauc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1875623